LTFS
IBIO icon

Ladenburg Thalmann Financial Services’s iBio IBIO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
2
– – ﹤0.01% 5403
2019
Q3 		$1K Buy
+2
New +$673 ﹤0.01% 5112
2019
Q2 		– Hold
0
– – – 5335
2019
Q1 		– Hold
0
– – – 5263
2018
Q4 		– Hold
0
– – – 5256

Other funds holding IBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ladenburg Thalmann Financial Services's IBIO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its iBio (IBIO) position steady in Q4 2019 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5403.

Ladenburg Thalmann Financial Services first reported a position in IBIO in Q3 2019 and has held it in 2 quarters since. The position peaked at $1K in Q3 2019. 16 funds tracked by Wall St. Rank hold IBIO as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2 shares of iBio worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its iBio share count unchanged in Q4 2019.
  • iBio made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5403 holding.
  • Ladenburg Thalmann Financial Services first reported a position in iBio in Q3 2019 and has held it in 2 quarters since.
  • Ladenburg Thalmann Financial Services's iBio position peaked at $1K in Q3 2019.
  • 16 funds tracked by Wall St. Rank held iBio as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.